Some white blood cells, appropriately called killer T cells, can kill cancer cells. Unfortunately, cancers can evolve resistance
to killer T cell attack by exploiting natural ‘immune checkpoints’. Immunologist Robert Nibbs explains how exciting new medicines can block these checkpoints, freeing killer T cells to kill cancers.

Read the full article: Releasing the cancer killers

First published: 17 August 2021

<< Life Sciences resources